Lloyd’s Register (LR) has updated its Fatigue Design Assessment (FDA) methodology, improving fatigue life predictions by up to 15 per cent for containerships and 10 per cent for gas carriers.
The findings, based on an 11-year analysis of global Automatic Identification System (AIS) data, mark the first major revision to FDA trading route assumptions in over 12 years and deliver more accurate structural lifespan estimates by reflecting actual vessel routing and operations.
The new approach replaces historical estimates with real-world data, enabling more precise calculations of how long a vessel’s structure can endure before fatigue becomes a concern.
Shipowners and operators can now benefit from better-informed decisions on design, maintenance, and operational planning.
The analysis also revealed that modern ships are operating differently from previous models, particularly in terms of route and weather optimisation.
Container vessel categorisation has been refined to align with today’s fleet.
Ultra Large Container Vessels (ULCVs) – those with 14,501 TEUs or more – are now explicitly included, alongside updated classifications for New Panamax (10,000–14,500 TEUs), Post-Panamax (5,101–10,000 TEUs), Panamax (3,001–5,100 TEUs), Feedermax (2,001–3,000 TEUs), and Feeder (1,001–2,000 TEUs) vessels.
Nick Gross, Global Containerships Segment Director at Lloyd’s Register, said: “This comprehensive update to our Fatigue Design Assessment methodology represents a significant advancement in how we evaluate vessel structural integrity.
“Our analysis of extensive AIS data revealed that ships are operating quite differently from our previous models, particularly in terms of route optimisation and weather routing. This translates directly into improved fatigue life predictions that shipowners can rely on for better operational and maintenance planning.”
The enhanced FDA methodology is available for shipowners, designers, and operators seeking the latest in vessel structural assessment.
